A citation-based method for searching scientific literature

Lucas Schirmer, Dorothy P Schafer, Theresa Bartels, David H Rowitch, Peter A Calabresi. Trends Immunol 2021
Times Cited: 22







List of co-cited articles
122 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Transcriptomic profiling of microglia and astrocytes throughout aging.
Jie Pan, Nana Ma, Bo Yu, Wei Zhang, Jun Wan. J Neuroinflammation 2020
64
9

Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides.
Milla Koistinaho, Suizhen Lin, Xin Wu, Michail Esterman, Deanna Koger, Jeffrey Hanson, Richard Higgs, Feng Liu, Seema Malkani, Kelly R Bales,[...]. Nat Med 2004
436
9

TREM2 Maintains Microglial Metabolic Fitness in Alzheimer's Disease.
Tyler K Ulland, Wilbur M Song, Stanley Ching-Cheng Huang, Jason D Ulrich, Alexey Sergushichev, Wandy L Beatty, Alexander A Loboda, Yingyue Zhou, Nigel J Cairns, Amal Kambal,[...]. Cell 2017
514
9

The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases.
Susanne Krasemann, Charlotte Madore, Ron Cialic, Caroline Baufeld, Narghes Calcagno, Rachid El Fatimy, Lien Beckers, Elaine O'Loughlin, Yang Xu, Zain Fanek,[...]. Immunity 2017
9

The microglial sensome revealed by direct RNA sequencing.
Suzanne E Hickman, Nathan D Kingery, Toshiro K Ohsumi, Mark L Borowsky, Li-chong Wang, Terry K Means, Joseph El Khoury. Nat Neurosci 2013
923
9

Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution.
Takahiro Masuda, Roman Sankowski, Ori Staszewski, Chotima Böttcher, Lukas Amann, Sagar, Christian Scheiwe, Stefan Nessler, Patrik Kunz, Geert van Loo,[...]. Nature 2019
524
9

Microglial regional heterogeneity and its role in the brain.
Yun-Long Tan, Yi Yuan, Li Tian. Mol Psychiatry 2020
172
9


APOE and TREM2 regulate amyloid-responsive microglia in Alzheimer's disease.
Aivi T Nguyen, Kui Wang, Gang Hu, Xuran Wang, Zhen Miao, Joshua A Azevedo, EunRan Suh, Vivianna M Van Deerlin, David Choi, Kathryn Roeder,[...]. Acta Neuropathol 2020
51
9

Variant of TREM2 associated with the risk of Alzheimer's disease.
Thorlakur Jonsson, Hreinn Stefansson, Stacy Steinberg, Ingileif Jonsdottir, Palmi V Jonsson, Jon Snaedal, Sigurbjorn Bjornsson, Johanna Huttenlocher, Allan I Levey, James J Lah,[...]. N Engl J Med 2013
9

Clinical epidemiology of Alzheimer's disease: assessing sex and gender differences.
Michelle M Mielke, Prashanthi Vemuri, Walter A Rocca. Clin Epidemiol 2014
523
9

Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner.
Dorothy P Schafer, Emily K Lehrman, Amanda G Kautzman, Ryuta Koyama, Alan R Mardinly, Ryo Yamasaki, Richard M Ransohoff, Michael E Greenberg, Ben A Barres, Beth Stevens. Neuron 2012
9

Synaptic pruning by microglia is necessary for normal brain development.
Rosa C Paolicelli, Giulia Bolasco, Francesca Pagani, Laura Maggi, Maria Scianni, Patrizia Panzanelli, Maurizio Giustetto, Tiago Alves Ferreira, Eva Guiducci, Laura Dumas,[...]. Science 2011
9


A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease.
Hadas Keren-Shaul, Amit Spinrad, Assaf Weiner, Orit Matcovitch-Natan, Raz Dvir-Szternfeld, Tyler K Ulland, Eyal David, Kuti Baruch, David Lara-Astaiso, Beata Toth,[...]. Cell 2017
9

Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAE.
Marina O Ziehn, Andrea A Avedisian, Seema Tiwari-Woodruff, Rhonda R Voskuhl. Lab Invest 2010
143
9

Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients.
Ranjan Dutta, Ansi Chang, Mary K Doud, Grahame J Kidd, Michael V Ribaudo, Elizabeth A Young, Robert J Fox, Susan M Staugaitis, Bruce D Trapp. Ann Neurol 2011
220
9

Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis.
Robert Nisticò, Dalila Mango, Georgia Mandolesi, Sonia Piccinin, Nicola Berretta, Marco Pignatelli, Marco Feligioni, Alessandra Musella, Antonietta Gentile, Francesco Mori,[...]. PLoS One 2013
115
9

Neural Circuit-Specialized Astrocytes: Transcriptomic, Proteomic, Morphological, and Functional Evidence.
Hua Chai, Blanca Diaz-Castro, Eiji Shigetomi, Emma Monte, J Christopher Octeau, Xinzhu Yu, Whitaker Cohn, Pradeep S Rajendran, Thomas M Vondriska, Julian P Whitelegge,[...]. Neuron 2017
353
9


The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment.
Andrew P Robinson, Christopher T Harp, Avertano Noronha, Stephen D Miller. Handb Clin Neurol 2014
258
9

Identifying CNS-colonizing T cells as potential therapeutic targets to prevent progression of multiple sclerosis.
Max Kaufmann, Hayley Evans, Anna-Lena Schaupp, Jan Broder Engler, Gurman Kaur, Anne Willing, Nina Kursawe, Charlotte Schubert, Kathrine E Attfield, Lars Fugger,[...]. Med (N Y) 2021
23
9

Drug exposure and the risk of multiple sclerosis: A systematic review.
Heather Y Yong, Kyla A McKay, Cole G J Daley, Helen Tremlett. Pharmacoepidemiol Drug Saf 2018
7
14

A pilot, open label, clinical trial using hydroxyzine in multiple sclerosis.
L Logothetis, I A Mylonas, S Baloyannis, M Pashalidou, A Orologas, A Zafeiropoulos, V Kosta, T C Theoharides. Int J Immunopathol Pharmacol 2005
40
4

Identification of Bphs, an autoimmune disease locus, as histamine receptor H1.
Runlin Z Ma, Jianfeng Gao, Nathan D Meeker, Parley D Fillmore, Kenneth S K Tung, Takeshi Watanabe, James F Zachary, Halina Offner, Elizabeth P Blankenhorn, Cory Teuscher. Science 2002
113
4

The histamine H3 receptor and eating behavior.
Maria Beatrice Passani, Patrizio Blandina, Fernando Torrealba. J Pharmacol Exp Ther 2011
56
4

Serum levels of histamine and diamine oxidase in multiple sclerosis.
Aryan Rafiee Zadeh, Masih Falahatian, Fereshteh Alsahebfosoul. Am J Clin Exp Immunol 2018
19
5

AVN-101: A Multi-Target Drug Candidate for the Treatment of CNS Disorders.
Alexandre V Ivachtchenko, Yan Lavrovsky, Ilya Okun. J Alzheimers Dis 2016
21
4



Histamine H3 receptor antagonists/inverse agonists: Where do they go?
Nakisa Ghamari, Omid Zarei, José-Antonio Arias-Montaño, David Reiner, Siavoush Dastmalchi, Holger Stark, Maryam Hamzeh-Mivehroud. Pharmacol Ther 2019
36
4

Meningeal and cortical grey matter pathology in multiple sclerosis.
Bogdan F Gh Popescu, Claudia F Lucchinetti. BMC Neurol 2012
132
4

Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging.
Olga Ciccarelli, Frederik Barkhof, Benedetta Bodini, Nicola De Stefano, Xavier Golay, Klaas Nicolay, Daniel Pelletier, Petra J W Pouwels, Seth A Smith, Claudia A M Wheeler-Kingshott,[...]. Lancet Neurol 2014
152
4

The Histamine H3 Receptor: Structure, Pharmacology, and Function.
Gustavo Nieto-Alamilla, Ricardo Márquez-Gómez, Ana-Maricela García-Gálvez, Guadalupe-Elide Morales-Figueroa, José-Antonio Arias-Montaño. Mol Pharmacol 2016
91
4

Microglia and Central Nervous System-Associated Macrophages-From Origin to Disease Modulation.
Marco Prinz, Takahiro Masuda, Michael A Wheeler, Francisco J Quintana. Annu Rev Immunol 2021
103
4


Systemic lack of canonical histamine receptor signaling results in increased resistance to autoimmune encephalomyelitis.
Naresha Saligrama, Laure K Case, Roxana del Rio, Rajkumar Noubade, Cory Teuscher. J Immunol 2013
23
4

Histamine Intolerance: The Current State of the Art.
Oriol Comas-Basté, Sònia Sánchez-Pérez, Maria Teresa Veciana-Nogués, Mariluz Latorre-Moratalla, María Del Carmen Vidal-Carou. Biomolecules 2020
50
4

The histamine H4 receptor: from orphan to the clinic.
Robin L Thurmond. Front Pharmacol 2015
80
4

Modulation of P2X7 Receptor during Inflammation in Multiple Sclerosis.
Susanna Amadio, Chiara Parisi, Eleonora Piras, Paola Fabbrizio, Savina Apolloni, Cinzia Montilli, Sabina Luchetti, Serena Ruggieri, Claudio Gasperini, Franco Laghi-Pasini,[...]. Front Immunol 2017
43
4

Modeling multiple sclerosis in laboratory animals.
Bettina Schreiner, Frank L Heppner, Burkhard Becher. Semin Immunopathol 2009
40
4

H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects.
R Leurs, M K Church, M Taglialatela. Clin Exp Allergy 2002
258
4


Immethridine, histamine H3-receptor (H3R) agonist, alleviated experimental autoimmune encephalomyelitis via inhibiting the function of dendritic cells.
Yaru Shi, Zhenlong Li, Ran Chen, Jiang Zhang, Xuefei Hu, Cong He, Qiong Su, Hongdou Ma, Hua Ren, Min Qian,[...]. Oncotarget 2017
8
12

Transdermal histamine in multiple sclerosis: part one -- clinical experience.
G Gillson, J V Wright, E DeLack, G Ballasiotes. Altern Med Rev 1999
12
8

Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression.
Savina Apolloni, Paola Fabbrizio, Susanna Amadio, Cinzia Volonté. J Neuroinflammation 2016
43
4

Novel compounds with dual S1P receptor agonist and histamine H3 receptor antagonist activities act protective in a mouse model of multiple sclerosis.
Faik Imeri, Bisera Stepanovska Tanturovska, Aleksandra Zivkovic, Gaby Enzmann, Stephanie Schwalm, Josef Pfeilschifter, Thomas Homann, Burkhard Kleuser, Britta Engelhardt, Holger Stark,[...]. Neuropharmacology 2021
6
16

Histamine and Immune Biomarkers in CNS Disorders.
Ramón Cacabelos, Clara Torrellas, Lucía Fernández-Novoa, Francisco López-Muñoz. Mediators Inflamm 2016
30
4

Important role of mast cells in multiple sclerosis.
P Conti, D Kempuraj. Mult Scler Relat Disord 2016
36
4

Immunoregulatory Effects of Tolerogenic Probiotics in Multiple Sclerosis.
Hadi Atabati, Esmaeil Yazdanpanah, Hamed Mortazavi, Saeed Gharibian Bajestani, Amir Raoofi, Seyed-Alireza Esmaeili, Azad Khaledi, Ehsan Saburi, Jalil Tavakol Afshari, Thozhukat Sathyapalan,[...]. Adv Exp Med Biol 2021
8
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.